Marisol Soengas, Head of the CNIO Melanoma Group. /CNIO
The CNIO researcher has been recognised for the quality and impact of her basic and applied research in melanoma
She is the third woman and the first Spaniard to receive this award
“Every award is important, but when it comes from key leaders in skin oncology, you feel absolutely delighted,” she says
Marisol Soengas, leader of the Melanoma Group at the Spanish National Cancer Research Centre (CNIO), has been awarded the Fritz Anders Medal by the European Society for Pigment Cell Research (ESPCR). Soengas received this Medal at the 22nd ESPCR Meeting, held at the Palais des Académies, in Brussels. This was in recognition of the outstanding achievements in basic and translational melanoma research of Soengas as well as for on the impact of his group towards improving ways to treat melanoma, the most aggressive type of skin cancer.
Soengas and her research team have had major achievements, like the discovery of mechanisms that distinguish benign nevi from melanoma, the identification of factors that define the “barcode” of melanoma, namely, intrinsic signatures that distinguish this disease from over 25
Soengas is the third woman and the first Spaniard to receive the Fritz Anders Medal. “I cherish every award,” she says, “but when it is the most outstanding professionals in your field that honour you, you feel absolutely delighted.”
Marisol Soengas is the recipient of other accolades, including among others, the L’Oréal Paris USA-MRA Team Science Award for Women in Scientific Research, given by the Melanoma Research Alliance (MRA) to an international multi-institutional research team led by Soengas; The Outstanding Research Award by the Society for Melanoma Research, the Constantes y Vitales Award, given by